Tag: Angiogenesis inhibitors/therapeutic use

Effect of anti-vascular endothelial growth factor therapy on wet age-related macular degeneration and its recurrence factors

2021, No. 01, Clinical Science

Authors: Cheng Zifang,  Wang Yusheng,  Wang Haiyan,  Sun Dongjie,  Zhu Jinting,  Li Manhong DOI: 10.3760/cma.j.cn115989-20201104-00743 Published 2021-01-10 Cite as Chin J Exp Ophthalmol, 2021,39(01): 20-26. Abstract                                    [View PDF] [Read Full Text]                […]

Effect of attenuated-dose aflibercept intravitreal injection on retinopathy of prematurity

2021, No. 01, Clinical Science

Authors: Long Yang,  Wan Weiwei,  Liu Hongzhuo,  Wan Wencui DOI: 10.3760/cma.j.cn115989-20200705-00477 Published 2021-01-10 Cite as Chin J Exp Ophthalmol, 2021,39(01): 47-52. Abstract                              [View PDF] [Read Full Text] Objective To observe the effect of attenuated-dose aflibercept in the treatment of retinopathy of […]

Influence factors and strategies of anti-VEGF therapy for wet AMD

2016, No. 01, Editorial

Authors: Dai Hong,  Lu Yingyi DOI: 10.3760/cma.j.issn.2095-0160.2016.01.001 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 1-4. Abstract                            [Download PDF] [Read Full Text] Neovascular age-related macular degeneration is also known as wet age-related macular degeneration (wAMD), which is now one of potentially blinding diseases in elder population worldwide.The […]